NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.250
+0.040 (3.30%)
Jul 30, 2026, 10:33 AM EDT - Market open
NuCana Market Cap
NuCana has a market cap or net worth of $5.2 million as of July 30, 2026. Its market cap has increased by 1,200.48% in one year.
Market Cap
5.20M
Enterprise Value
-22.49M
1-Year Change
1,200.48%
Ranking
Category
Stock Price
$1.25
ChartMarket Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $5.20M, a decrease of -98.99%. That is a compound annual growth rate of -40.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 5.40M | -64.00% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 5.36M |
| Soligenix | 5.36M |
| BioAtla | 5.34M |
| AIM ImmunoTech | 5.30M |
| SciSparc | 5.21M |
| GeoVax Labs | 5.15M |
| Aptevo Therapeutics | 4.96M |
| Enveric Biosciences | 4.90M |